Document Detail


Low-Molecular-Weight Heparin Versus Aspirin for Acute Ischemic Stroke With Large Artery Occlusive Disease: Subgroup Analyses From the Fraxiparin in Stroke Study for the Treatment of Ischemic Stroke (FISS-tris) Study.
MedLine Citation:
PMID:  22076004     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND AND PURPOSE: The Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) study showed no superiority of low-molecular-weight heparin (LMWH) over aspirin for the primary end point (Barthel Index) in acute ischemic stroke due to large artery occlusive disease. This study aims to evaluate the efficacy of LMWH and aspirin in selected subgroups so as to generate hypotheses for further studies. METHODS: The FISS-tris study was a multicenter, randomized trial to investigate the efficacy and safety of LMWH (nadroparin calcium 3800 antifactor Xa IU/0.4 mL subcutaneously twice daily) or aspirin (160 mg once daily) for the treatment of patients with acute ischemic stroke and large artery occlusive disease. The primary outcome was the Barthel Index score dichotomized at 85 6 months poststroke. Exploratory subgroup analysis was performed using different levels of baseline characteristics and the distribution of symptomatic arteries. RESULTS: Compared with aspirin, LMWH improved outcome among older patients >68 years (P=0.043; OR, 1.86; 95% CI, 1.02-3.41) without ongoing antiplatelet treatment on admission (P=0.029; OR, 1.85; 95% CI, 1.06-3.21) and with symptomatic posterior circulation arterial disease (P=0.001; OR, 5.76; 95% CI, 2.00-16.56). CONCLUSIONS: Our findings suggest that LMWH may be of benefit in certain subgroups of patients with acute cerebral infarct and large artery occlusive disease. Hence, further investigation of LMWH may be justified in subgroups such as the elderly, nonusers of antiplatelet agents, and patients with posterior circulation stenosis.Clinical Trial Registration-URL: www.strokecenter.org/trials. Unique identifier: registration no. 493.
Authors:
Qiao Shu Wang; Christopher Chen; Xiang Yan Chen; Jing Hao Han; Yannie Soo; Thomas W Leung; Vincent Mok; Ka Sing Lawrence Wong
Related Documents :
1191434 - Pulmonary valve echo motion in pulmonary regurgitation.
8355554 - Endothelin peptides: biological actions and pathophysiological significance in the lung.
9465314 - Haemodynamic correlation with lung biopsy findings in isolated ventricular septal defec...
1478564 - Pulmonary arteries dimensions and their dependences on the age, the height and body wei...
2787604 - Canine arteries release two different endothelium-derived relaxing factors.
16894254 - Percutaneous valve interventions: where we are and where we are headed.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-11-10
Journal Detail:
Title:  Stroke; a journal of cerebral circulation     Volume:  -     ISSN:  1524-4628     ISO Abbreviation:  -     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0235266     Medline TA:  Stroke     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
From the Department of Neurology, Shanghai First People's Hospital, Medical College, Shanghai Jiao Tong University, Shanghai, PR China; the Department of Pharmacology, National University of Singapore, Singapore; and the Departments of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Activation of Signal Transducer and Activator of Transcription-3 by a Peroxisome Proliferator-Activa...
Next Document:  Moderate Dietary Restriction Reduces p53-Mediated Neurovascular Damage and Microglia Activation Afte...